risperidone 37.5 MG Injection
- RxCUI
- 402011
- RxNorm name
- risperidone 37.5 MG Injection
- Display name
- risperidone 37.5 MG Injection
- Full name
- risperidone 37.5 MG Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:18
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Risperidone | RISPERIDONE | Amneal Pharmaceuticals LLC | d526af85-ee70-4657-a27e-d451027ffd9e | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 402011 |
| Rykindo extended-release microspheres | RISPERIDONE | Shandong Luye Pharmaceutical Co., Ltd. | 58534c96-96f5-4c2e-a061-92d4506aee91 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 402011 |
| risperidone | RISPERIDONE | Lupin Pharmaceuticals, Inc. | b462e48c-ef1d-4591-8fca-6b5829d8ed90 | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | 402011 |
| RISPERDAL CONSTA | RISPERIDONE | Janssen Pharmaceuticals, Inc. | bb34ee82-d2c2-43b8-ba21-2825c0954691 | 2025-11-05 | Boxed warning, Warnings, Adverse reactions | 402011 |
| Risperidone | RISPERIDONE | Teva Pharmaceuticals, Inc. | 32c0f081-b418-4c1c-b39e-eb5c344043c7 | 2025-02-28 | Boxed warning, Warnings, Adverse reactions | 402011 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| bb34ee82-d2c2-43b8-ba21-2825c0954691 | risperidone 37.5 MG Injection | SCD | 38 | These highlights do not include all the information needed to use RISPERDAL CONSTA ® safely and effectively. See full prescribing information for RISPERDAL CONSTA ® . . RISPERDAL CONSTA ® (risperidone) LONG-ACTING INJECTION Initial U.S. Approval: 2003 | 20251105 |
| bb34ee82-d2c2-43b8-ba21-2825c0954691 | risperiDONE 37.5 MG Extended Release Injection | PSN | 38 | These highlights do not include all the information needed to use RISPERDAL CONSTA ® safely and effectively. See full prescribing information for RISPERDAL CONSTA ® . . RISPERDAL CONSTA ® (risperidone) LONG-ACTING INJECTION Initial U.S. Approval: 2003 | 20251105 |
| 58534c96-96f5-4c2e-a061-92d4506aee91 | risperidone 37.5 MG Injection | SCD | 10 | These highlights do not include all the information needed to use RYKINDO ® safely and effectively. See full prescribing information for RYKINDO ® . RYKINDO ® (risperidone) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 1993 | 20260526 |
| 58534c96-96f5-4c2e-a061-92d4506aee91 | risperiDONE 37.5 MG Extended Release Injection | PSN | 10 | These highlights do not include all the information needed to use RYKINDO ® safely and effectively. See full prescribing information for RYKINDO ® . RYKINDO ® (risperidone) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 1993 | 20260526 |
| d526af85-ee70-4657-a27e-d451027ffd9e | risperiDONE 37.5 MG Extended Release Injection | PSN | 6 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | 20250706 |
| d526af85-ee70-4657-a27e-d451027ffd9e | risperidone 37.5 MG Injection | SCD | 6 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | 20250706 |
| b462e48c-ef1d-4591-8fca-6b5829d8ed90 | risperiDONE 37.5 MG Extended Release Injection | PSN | 4 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION. RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | 20260224 |
| b462e48c-ef1d-4591-8fca-6b5829d8ed90 | risperidone 37.5 MG Injection | SCD | 4 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION. RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | 20260224 |
| 32c0f081-b418-4c1c-b39e-eb5c344043c7 | risperidone 37.5 MG Injection | SCD | 3 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | 20250228 |
| 32c0f081-b418-4c1c-b39e-eb5c344043c7 | risperiDONE 37.5 MG Extended Release Injection | PSN | 3 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | 20250228 |